| Detected | Trial | Change |
|---|---|---|
| 2026-06-05 | NCT07086976 A Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Oral Rilzabrutinib… |
Trial sites expanded: 92 -> 95 locations |
| 2026-05-28 | NCT07007962 Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune… |
Trial sites expanded: 24 -> 30 locations |
| 2026-05-23 | NCT07190196 A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults… |
Trial sites expanded: 68 -> 74 locations |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT06975865 | The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With… | Sickle Cell Disease | Recruiting |
| NCT07007962 | Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune… | Immune Thrombocytopenia | Recruiting |
| NCT07190196 | A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults… | Immunoglobulin G4 Related Disease | Recruiting |
| NCT07086976 | A Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Oral Rilzabrutinib… | Autoimmune Haemolytic Anaemia | Recruiting |
| NCT04562766 | Study to Evaluate Rilzabrutinib in Adults and Adolescents With Persistent or Chronic… | Immune Thrombocytopenia | Active, Not Recruiting |
| Phase 2 | |||
| NCT06984627 | A Study to Investigate the Efficacy and Safety of Rilzabrutinib in Adult Participants… | Graves' Disease | Recruiting |
| NCT06500702 | A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib… | Focal Segmental Glomerulosclerosis | Recruiting |
| NCT05002777 | Efficacy, Safety and Pharmacokinetics of Rilzabrutinib in Patients With Warm Autoimmune… | Warm Autoimmune Hemolytic Anemia (wAIHA) | Active, Not Recruiting |